Start-Up Claims to Use A.I.-Created Viruses to Treat a Patient

Biotech firm Adaptive Phage Therapeutics has treated a patient using a bacteriophage engineered with the assistance of artificial intelligence. This clinical application aims to target drug-resistant bacterial infections that are otherwise difficult to eradicate. By utilizing generative models to refine how these viruses interact with pathogens, researchers hope to accelerate the development of personalized antimicrobial therapies. The successful administration of this treatment marks a shift toward integrating computational design into phage-based medicine.